SEC Insider Transactions from Rotman Harris.

Last updated: 2026-03-14 11:26 UTC | Total transactions: 9

Rotman Harris has filed 9 insider transactions across 1 company since September 2023.

Most recent transaction: a grant/award of 37500 shares of Centessa Pharmaceuticals plc ($CNTA) on February 01, 2024.

Activity breakdown: 0 open-market purchases and 2 sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 1, 2024 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs A Ordinary Shares 37500 $0.00 71,000.0000 0 111.94% 0.00%
Feb. 1, 2024 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs F Ordinary Shares 4108 $8.19 66,892.0000 0 5.79% 0.00%
Feb. 1, 2024 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs S Ordinary Shares 4267 $8.10 62,625.0000 0 6.38% 0.00%
Feb. 1, 2024 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs A Share Option (right to buy) 75000 $0.00 75,000.0000 0 9999.99% 0.00%
Sept. 20, 2023 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs M Ordinary Shares 31250 $4.47 64,750.0000 0 93.28% 0.00%
Sept. 20, 2023 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs M Ordinary Shares 6234 $3.85 70,984.0000 0 9.63% 0.00%
Sept. 20, 2023 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs S Ordinary Shares 37484 $6.29 33,500.0000 0 52.81% 0.00%
Sept. 20, 2023 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs M Share Option (right to buy) 31250 $0.00 93,750.0000 0 25.00% 0.00%
Sept. 20, 2023 Centessa Pharmaceuticals plc $CNTA Rotman Harris SVP Regulatory Affairs M Share Option (right to buy) 6234 $0.00 43,666.0000 0 12.49% 0.00%